phase readout

NCT06609005: A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

RECRUITINGupdated 19d ago

community read0 votes

Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.. Phase: PHASE1. Conditions: Advanced Metastatic Castration Resistant Prostate Cancer

Data sources

last refreshed 59m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?